Why the study?
Does baseline hs-CRP level predict 12-month all-cause mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention, stratified by body mass index?
Does baseline hs-CRP level predict 12-month all-cause mortality in patients with acute myocardial infarction undergoing percutaneous coronary intervention, stratified by body mass index?
Answers are grounded in this paper and cite their sources.
Elevated baseline hs-CRP (≥4.08 mg/dL) is an independent predictor of 12-month all-cause mortality in overweight and obese patients presenting with AMI and undergoing PCI.
BACKGROUND AND OBJECTIVES: Serum high sensitivity C-reactive protein (hs-CRP) is a marker of inflammation and may lead to the development of atherosclerosis, adversely affecting mortality. The aim of this study was to evaluate the relationship between baseline hs-CRP level and 12-month clinical outcomes in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) according to their body mass index (BMI) status. SUBJECTS AND METHODS: Using data from the Korea Acute Myocardial Infarction Registry from November 2005 to September 2008, a total of 8174 consecutive AMI patients were studied. Cox proportional hazard model revealed that higher baseline levels of hs-CRP was associated with 12-month all-cause mortality (p=0.045). To further understand this association, patients were divided into 3 groups based on their body mass index: 1) overweight/obese, 2) normal weight, and 3) underweight patients. Then each group was stratified into quartiles based on their hs-CRP. RESULTS: In overweight/obese patients, Cox model showed significant association of hs-CRP with 12-month mortality when adjusted for age and gender (p<0.001), however, after adjustment with multiple covariates, mortality was highest in the 4th quartile {HR 2.382, (1.079-5.259), p=0.032} though statistically insignificant (p=0.172). We observed no significant association of serum hs-CRP with 12-month mortality in normal weight (p=0.681) and underweight (p=0.760) patients. CONCLUSION: Higher baseline hs-CRP level (≥4.08 mg/dL) in overweight/obese AMI patients showed significant association with 12-month all-cause mortality independent of other prognostic markers.
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: